Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience

Gönülal M, Balcı DD, Öztürkcan S

Clinical, Cosmetic and Investigational Dermatology 2023, 16:3653-3659

Published Date: 20 December 2023